Several factors associated with GLP-1 therapy may contribute to this process
Sarika Arora, MD Ozempic and Wegovy are the leading brand names among a class of weight loss drugs known as GLP-1 receptor agonists (GLP-1 RAs)
FDA-approved prescribing information for all GLP-1 medications specifies incremental dose increases over weeks to months
Between 2023 and 2045, many key patents will expire, opening the door to generics and forcing originators to diversify protection strategies

CrossRef Childhood Underweight and Adulthood Obesity Associated With Increased Risk of MASLD and Cirrhosis: A Prospective Cohort Study of 375,125 Adults Jiadong Zeng, Jian Liang, Hao Zhang, Hanming Wang, zheyang Lin, Wenzhe Zhang, Haobin Zhang, Xudong Deng, Jiahui Lin, Minqi Liu, Minwen Chen, Yue Qiu, Zhen Zhang, Zhaohua Zhu, Yi Zeng Hepatology Research .2026;[Epub] CrossRef Dietary folate intake and metabolic dysfunction-associated steatotic liver disease: a prospective cohort study Qingchun Li, Xinyu Zhang, Fengyuan Zhao, Dongfeng Zhang, Weijing Wang, Zhongyang Zhang, Feng Yang Nutrition & Metabolism .2026;[Epub] CrossRef Comorbid type 2 diabetes and cardiovascular disease drive higher healthcare costs in MASLD/MASH: a retrospective Swedish cohort study Helena Skrder, Mattias Ekstedt, Stergios Kechagias, Riku Ota, Ying Shang, Fotis Tefos, Emilie Toresson Grip, Johan Vessby, Hannes Hagstrm Scandinavian Journal of Gastroenterology .2026